Results 281 to 290 of about 162,494 (358)

Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Reversal of Anticoagulation: Evaluation of Efficacy, Safety, and Cost Savings. [PDF]

J Hematol
Al Homssi A, Lokkesmoe R, Powers R, Jung B, Chunara F, Szabo A, Baumann Kreuziger L.   +6 more
europepmc   +1 more source

Protein C activity in patients treated with warfarin after replacement by prosthetic heart valve or peripheral arterial reconstruction surgery.

, 1989
Tetsuya Osada, Hiroshi Yamaguchi, Shin Ishimaru, Kinichi Furukawa, K Kuroso, M Fujimaki   +5 more
openalex   +2 more sources

Patient‐Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Circulation, Volume 15, Issue 4, October 2025.
ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension that is caused by persistent obstruction of the pulmonary arteries by organized thrombi and associated microvascular disease. Pulmonary endarterectomy (PEA) is the gold standard treatment, but the extent of small vessel remodeling, which strongly ...
Behdad Shaarbaf Ebrahimi, Prashanna Khwaounjoo, Ho‐Fung Chan, Finbar Argus, Xiaohui Ma, Martyn P. Nash, Atsuo Doi, Misha Dagan, David M. Kaye, Timothy Joseph, David McGiffin, Merryn H. Tawhai   +11 more
wiley   +1 more source

Comparison of Apixaban With Warfarin in Patients on Dialysis Within an Integrated Health Care System. [PDF]

Perm J
Shaheed T, Stram D, Shirazi A, Iwasaki S, Davila C, Zheng S.   +5 more
europepmc   +1 more source

An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension—Case Report and Literature Review

Respirology Case Reports, Volume 13, Issue 10, October 2025.
We report a rare case of CTEPH presenting with an aseptic cavitary pulmonary infarction, an unusual manifestation typically mimicking infection or malignancy. This case underscores the need for genetic screening in unexplained CTEPH, as thrombophilia workup in our case revealed a heterozygous Factor V Leiden mutation (an uncommon congenital risk factor
Vinay Venugopal, Saurabh Karmakar, Rajesh Kumar Yadav, Abdul Raouf Wani, Debapriya Maji, Gaurav Kumar Singh   +5 more
wiley   +1 more source

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. [PDF]

J Am Heart Assoc
Lee TTL, Ju C, Chan SCL, Chou OHI, Chan JSK, Lee S, Liu T, Cheng SH, Zhang Y, Cheung BMY, Wai AK, Wei L, Tse G.   +12 more
europepmc   +1 more source

The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats

Journal of Pharmacy and Pharmacology, 1972
openaire   +3 more sources

Desmoid tumor in pregnancy complicated by deep vein thrombosis: A case report. [PDF]

Case Rep Womens Health
Suntipap M, Kassayanan P, Nontaprom K.
europepmc   +1 more source

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT. [PDF]

JACC Adv
Shah JA, Hussain J, Ahmed B, Batra MK, Ali G, Naz M, Khan W, Bhatti KI, Karim M, Hakeem A.   +9 more
europepmc   +1 more source

Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise

FASEB BioAdvances, Volume 7, Issue 10, October 2025.
Calumenin (CALU) is effective in calcium homeostasis, involved in various cellular processes, ER‐related functions, normal calcification processes, pathological calcium deposits, inflammatory diseases, and cancers. Additionally, it has been linked to cancer by controlling the γ‐carboxylation of vitamin K‐dependent proteins linked to cancer.
Parinaz Nasri Nasrabadi, Babak Jahangiri, Zahra Amiri, Forouzandeh Mahjoubi, Fatemeh Masoumi, Alireza Zomorodipour   +5 more
wiley   +1 more source